LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
MCF7 CGP60474
0.37
uM
LJP5
3
F04
72
hr
1209 612 4093 0.1495 -0.2072
MDA-MB-231 NU7441
10.0
uM
LJP5
3
C07
72
hr
1235 1159 4513 0.2568 -0.0235
MDA-MB-231 Dactolisib
10.0
uM
LJP5
3
M13
72
hr
1235 1716 4513 0.3802 0.1465
Hs 578T XL147
10.0
uM
LJP5
3
G07
72
hr
658 3038 3846 0.7899 0.7465
MDA-MB-231 Palbociclib
10.0
uM
LJP6
3
E13
72
hr
1235 1696 4513 0.3758 0.1404
MDA-MB-231 PF562271
10.0
uM
LJP6
3
F13
72
hr
1235 501 4513 0.1110 -0.2242
MDA-MB-231 PD184352
10.0
uM
LJP5
3
L07
72
hr
1235 1600 4513 0.3545 0.1111
MDA-MB-231 PD0325901
10.0
uM
LJP6
3
E01
72
hr
1235 1030 4513 0.2282 -0.0628
MCF7 CGP60474
0.37
uM
LJP6
3
G04
72
hr
1209 766 4093 0.1872 -0.1538
MCF7 CP724714
0.37
uM
LJP5
3
A10
72
hr
1209 3788 4093 0.9255 0.8942
MDA-MB-231 PD173074
10.0
uM
LJP6
3
I07
72
hr
1235 1710 4513 0.3789 0.1446
BT-20 GSK 690693
0.12
uM
LJP5
3
F23
72
hr
1097 2899 3769 0.7691 0.6742
MCF7 CHIR-99021
0.37
uM
LJP6
3
P16
72
hr
1209 3690 4093 0.9015 0.8602
MDA-MB-231 PF431396
10.0
uM
LJP5
3
E07
72
hr
1235 435 4513 0.0964 -0.2444
MCF7 Crizotinib
0.37
uM
LJP5
3
A22
72
hr
1209 3246 4093 0.7931 0.7063
BT-20 PHA-793887
0.04
uM
LJP6
3
E24
72
hr
1097 2643 3769 0.7012 0.5784
MDA-MB-231 Pelitinib
10.0
uM
LJP5
3
I13
72
hr
1235 748 4513 0.1657 -0.1489
MDA-MB-231 PF477736
10.0
uM
LJP5
3
J19
72
hr
1235 921 4513 0.2041 -0.0961
MCF7 CP466722
0.37
uM
LJP5
3
I10
72
hr
1209 4211 4093 1.0288 1.0409
BT-20 WZ3105
0.37
uM
LJP5
3
D22
72
hr
1097 1209 3769 0.3207 0.0418